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Background: Observational studies have identified impaired lung function accessed by
forced expiratory volume in one second (FEV1), forced vital capacity (FVC) or the ratio
of FEV1 over FVC (FEV1/FVC) as an independent risk factor for atrial fibrillation (AF).
However, the result may be affected by confounders or reverse causality.
Methods: We performed univariable MR (uvMR), multivariable MR (mvMR) and
bidirectional two-sample MR to jointly estimate the causality of lung function with AF.
Apart from the inverse variance weighted (IVW) approach as the main MR analysis,
three complementary sensitive analyses approaches including MR-Egger regression,
weighted median (WM) MR and Pleiotropy Residual Sum and Outlier (MR-PRESSO) in
uvMR as well as mvMR-Egger and mvMR-PRESSO in mvMR were applied to control
for pleiotropy. Linkage disequilibrium score (LDSC) regression was applied to estimate
genetic correlation between lung function and AF.
Results: All forward and reverse uvMR analyses consistently suggested absent causal
relations between lung function and AF risk [forward IVW: odds ratio (OR)FEV1 = 1.031,
95% CI = 0.909–1.169, P = 0.630; ORFVC = 1.002, 95% CI = 0.834–1.204, P =
0.982; ORFEV1/FVC = 1.076, 95% CI = 0.966–1.199, P = 0.182; reverse IVW: ORFEV1
= 0.986, 95% CI = 0.966–1.007, P = 0.187; ORFVC = 0.985, 95% CI = 0.965–1.006,
P = 0.158; ORFEV1/FVC = 0.994, 95% CI = 0.973–1.015, P = 0.545]. The forward MREgger showed that each standard deviation (SD) increase in FEV1/FVC was related to a
higher AF risk (OR = 1.502, 95% CI = 1.178–1.915, P = 0.006) without heterogeneity
(Q_pval = 0.064), but pleiotropy effect exist (intercept = −0.017, P = 0.012). However,
this significant effect disappeared after adjustment of FEV1 and FVC (OR = 1.523, 95%
CI = 0.445–5.217, P = 0.503) in mvMR. No evidence was found for independent causal
effects of FEV1 and FVC on AF in mvMR analysis by using mvIVW method (ORFEV1 =
0.501, 95% CI = 0.056–4.457, P = 0.496; ORFVC = 1.969, 95% CI = 0.288–13.474,
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P = 0.490). Notably, the association between lung function and AF were replicated using
the FinnGen cohort data.
Conclusions: Our findings reported no coheritability between lung function and AF, and
failed to find substantial causal relation between decreased lung function and risk of AF.
However, lung function and AF were both associated with inflammation, which may be
potential pathway, warranting further study.
Keywords: forced expiratory volume in one second (FEV1), forced vital capacity (FVC), the ratio of FEV1 over FVC
(FEV1/FVC), atrial fibrillation (AF), bidirectional Mendelian randomization

INTRODUCTION

the role of FEV1/FVC, the inter-correlation of different lung
function traits as well as the independency of dataset of the SNPAF and SNP-lung function. Therefore, we integrated the uvMR,
mvMR and bidirectional MR approaches to identify causal
relation between lung function and AF using summary statistics
GWAS results in European population. Our study complements
published MR studies by including more lung function traits and
considering the overlap of datasets.

Atrial fibrillation (AF) is the most common persistent arrhythmia
and its prevalence increases with age (1). With the aging of
global population, AF with increased morbidity and mortality
has become an increasing public health burden (1–3). Published
observational studies (4–9) based on different ethnic-groups
indicated that declined lung function is related to higher
AF incidence.
Lung function accessed by forced expiratory volume in one
second (FEV1), forced vital capacity (FVC) and the ratio of
FEV1 over FVC (FEV1/FVC) are used to predict morbidity and
mortality associated with different airway disease (10–12) and
all-cause mortality (13). Compared with individuals in sinus
rhythm, more patients with persistent AF had lung function
below normal range (14). Meanwhile, higher AF prevalence was
found in subjects with severe impairment of lung function than
in those without or with mild/moderate impairment of lung
function (5).
The prevalence of AF and impaired lung function is increasing
worldwide and seriously affect the quality of life (15, 16),
so clarifying the direction and underlying causality of these
associations would be helpful to guide prevention. Age, gender,
height and smoking are strongly correlated with lung function
and AF, which are particularly important confounders (17–19).
Furthermore, due to the inter-correlations among different lung
function traits, identifying the causal effect of lung function on
AF is challenging and vice versa.
Mendelian randomization (MR) study may provide more
credible evidence concerning the causality of lung function and
AF. Genetic variants robustly related to lung function or AF
would be used as instrumental variables (IVs), respectively. Due
to the random allocation from parents to their offspring at
conception, IVs are less susceptible to confounders or reverse
causality (20, 21). Multivariable MR (mvMR) integrates a series
of pleiotropic SNPs (22) associated with at least one risk factors
as IVs to evaluate the causal influence of each risk factor on
the outcome. In addition, causal relation can be estimated even
if no variation shows a specific association with any individual
risk factor in the case of horizontal pleiotropy (23). Linkage
disequilibrium score (LDSC) regression could further explore
the association between lung function and AF by evaluating the
genetic correlation (24). A recent MR study (25) investigated the
causal inference of FEV1 and FVC on cardiovascular diseases
(CVDs) including AF. However, that study did not consider
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METHODS
Data Sources
Since this study only used publicly available summary statistic
from relevant genome-wide-association studies (GWAS) and did
not use the individual data, ethical approval was not required.

GWAS of AF
The study of Biobank-based GWAS tested association between
more than 30 million genetic variants and AF in 1,030,836
individuals (60,620 cases and 970,216 controls) of European
ancestry from the Nord-Trøndelag Health Study (HUNT),
deCODE, the Michigan Genomics Initiative (MGI), DiscovEHR,
UK Biobank, and the AFGen Consortium. Full details are
provided elsewhere (26).

GWAS of Lung Function (FEV1, FVC, and FEV1/FVC)
Summary genetic association estimates for lung function were
obtained from the largest currently available GWAS study in
400,102 individuals (UK Biobank: 321,407, SpiroMeta: 79,055)
of European ancestry and were adjusted for age, age2 , gender,
height, and smoking status. Given the datasets for AF included
individuals from UK Biobank, we just selected SpiroMeta results
from lung function GWAS to perform MR analyses. Because the
independence and non-overlapping of exposure and outcome
is a prominent prerequisite for the validity of the two sample
MR method (27). Full details are provided elsewhere (28) and
summary data are available online via LD-Hub (http://ldsc.
broadinstitute.org/ldhub/).
Considering the stability of our results, we replicated the twosample MR analysis using the above lung function GWAS data
including UK Biobank participants (SpiroMeta: 79,055 and UK
Biobank: 321,407) and another latest publicly available data of AF
(22,068 cases and 196,724 controls) released from the FinnGen
cohort (Release 5, https://www.finngen.fi/en).
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Instrumental Variables for Lung Function
and AF

(32). Results may be biased if IVs exhibit horizontal pleiotropy,
influencing outcomes by other pathways other than the exposure
(33). Therefore, we supplemented sensitivity analyses, including
the MR-Egger regression and weighted median (WM). The MREgger regression analysis allows free evaluation of the intercept
(not set to zero) as an indicator of average pleiotropic bias (33)
and gives a consistent estimate when all genetic variants are
invalid IVs. If more than half of the weight derived from effective
IVs, the WM method may come to an unbiased estimate of
causality (34). For mvMR, we used the extension of the IVW
approach (variants uncorrected, random effect model) which
performed multivariable weighted linear regression (33), and the
extension of the MR-Egger regression approach to correct for
both measured and unmeasured pleiotropy in mvMR (35).
To evaluate the robustness of significant results, we conducted
leave-one-out sensitivity analysis, the Cochran Q heterogeneity
test and I 2 statistics (36), and the MR Egger intercept test
(37) on horizontal pleiotropy to detect heterogeneity. In
addition, horizontal pleiotropy can be evaded by applying mvMR
approaches (i.e., by considering the overlapping IVs directly in
the estimation) (23). Pleiotropy Residual Sum and Outlier (MRPRESSO) was applied to detect and correct for outlier SNPs
reflecting pleiotropic biases (38).
The MR results are expressed as odds ratios (ORs) with
95% confidence intervals (CIs) interpreted as AF risk per
SD increase in log odds of the lung function traits (or
alternatively, the risk of impaired lung function per SD increase
in log odds of AF). We use a two-sided α of 0.017 based
on testing three lung function traits against AF outcome to
define significant or not. MR analyses were performed using
the packages “MendelianRandomization,” “TwoSampleMR,” and
“MR-PRESSO” packages (https://cran.r-project.org/package) in
the Rstudio (R version 4.0.3, R Project for Statistical Computing).
Power calculation was performed using mRnd developed by
Brion et al. (39) (https://cnsgenomics.com/shiny/mRnd/).

To interpret the resulting estimates as causal effects, three
common assumptions of IV estimation must hold: (1) the IV is
associated with the exposure robustly, (2) the IV is independent
of confounders, and (3) the IV influences the outcome exclusively
via the exposure (27).
We performed MR using genetic variants (significance of
SNPs: P < 5 × 10−8 ) associated with AF as IVs to investigate
their effect on lung function (FEV1, FVC, and FEV1/FVC),
and vice versa. Among others, violations of the second and
third assumption occur in case of population stratification,
when different ethnic subgroups are present with different allele
frequencies. We overcame this issue by focusing on individuals
with European ancestry (29). Violations of the third assumption
occur in case of linkage disequilibrium (LD) between the
included SNPs or in case of pleiotropy. Horizontal pleiotropy,
i.e., the same SNP independently influences multiple phenotypes,
leads to violations of the third assumption and to biased estimates
(27). In view of that, only independent variants (LD, r2 =
0.0001) based on European ancestry reference data from the
1,000 Genomes Project were retained.
In brief, the process for selecting IVs was as follows: we first
extract significant SNPs (P < 5 × 10−8 ) from exposure GWAS;
then prune SNPs for linkage disequilibrium (r2 = 0.0001);
next, extract the retained SNPs from the outcome datasets; last,
harmonize the exposure and outcome SNPs (e.g., removing the
SNPs for being palindromic with intermediate allele frequencies).
The mvMR approach takes into account the inter-relationship
between FEV1, FVC, and FEV1/FVC and the IVs used in the
mvMR analyses are often associated with all exposures. This
method is based on the above-mentioned standard IVs method
which allow for multiple exposures. We selected independent
SNPs (r2 < 0.0001) that were associated with FEV1, FVC, or
FEV1/FVC at P < 5 × 10−8 ; then we merged all SNPs related
to any lung-function traits by removing duplicate SNPs with
higher p-values; next, we extracted the relevant information of
the merged SNPs from the original exposure datasets; finally, we
used the last extracted SNPs as IVs for mvMR analysis.
We estimated the R2 [R2 = 2×EAF× (1-EAF) × Beta2 ] of
each SNP and summed them up to calculate the overall R2 and
F statistics [R2 × (N-2)/(1-R2 ); N represents the number of
individuals in the exposure GWAS] using the sample size of
exposure GWAS (30). Higher R2 and F statistic indicate lower
risk of weak IVs bias (31).

RESULTS
LDSC Regression
We performed LDSC analysis to estimate the genetic correlation
between lung function and AF as well as different lung-function
traits using LDSC software: https://github.com/bulik/ldsc. There

TABLE 1 | Genetic Correlation estimates from LDSC regression.

LDSC Regression Analysis
LDSC regression regresses χ 2 statistics for two phenotypes to
estimate SNP based coheritability on LDSCs. Genetic correlations
between lung function and AF can be evaluated by the regression
slope (24).

Phenotype 1

MR Analyses

FEV1

For uvMR, we used inverse variance weighted (IVW) method
as the main analysis. The IVW analysis does not consider the
intercept (constrained to zero) in the regression and uses the
reciprocal of the outcome variance as the weight for fitting
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Phenotype 2

Rg

se

P

FEV1

AF

NA

NA

NA

FVC

AF

NA

NA

NA

FEV1/FVC

AF

NA

NA

NA

FEV1/FVC

0.3859

0.0508

2.93e−14

FEV1

FVC

0.8717

0.0167

0.0

FVC

FEV1/FVC

−0.1287

0.0526

0.0144

FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the
ratio of FEV1 over FVC; AF, atrial fibrillation.
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FIGURE 1 | The flow chart of SNP selection for multivariate MR. SNPs are a set of instrumental variable related to FEV1 and/or FVC and/or FEV1/FVC. FEV1, forced
expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; SNP, single nucleotide polymorphism.

TABLE 2 | Baseline information of exposures used in our analyses.
Exposure

Outcome

Trait

Sample

Trait

FEV1

79,055

AF

1,030,836

FVC

79,055

AF

1,030,836

AF

1,030,836

FEV1/FVC

79,055

R2

Number of IVs
Sample

mvMR

uvMR

mvMR

9
28

8

Power (%)
uvMR

mvMR

uvMR

100

2

0.0059
0.0198

0.0045

16

F_statistics
mvMR

uvMR

1596.87

355.65

4

0.0125

467.76

38

991.84

AF

1,030,836

FEV1

79,055

–

82

–

0.1866

–

100

–

163,697.38

AF

1,030,836

FVC

79,055

–

82

–

0.1866

–

100

–

163,697.38

AF

1,030,836

FEV1/FVC

79,055

–

82

–

0.1866

–

100

–

163,697.38

FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; AF, atrial fibrillation; IVs, instrumental variables; R2 , Variance explained
by the SNPs on exposure.

rs13361953) represent the same signal, so we aggregate a list of
SNP (34 = 39 – 5) by selecting the SNPs with the lowest Pvalue. This resulted in 34 SNPs, of which seven were related
to FEV1 but not FVC and FEV1/FVC at P < 5 × 10−8 , 14
were associated with FEV1/FVC but not FEV1 and FVC at P
< 5 × 10−8 , eight were associated with FVC but not FEV1
and FEV1/FVC at P < 5 × 10−8 , and five were associated
with any two traits at P < 5 × 10−8 . Then, we extracted
relevant information of 34 SNPs from the original exposure
datasets, respectively. Finally, 28 (28 = 34–6, six palindrome
SNPs with intermediate allele frequencies were removed) SNPs
for any lung function trait were obtained after harmonizing with
SNP-outcome (the flow chart of SNPs selection was shown in
Figure 1).
The number of SNPs for FEV1 [nine, variance explained
(R2 ): 0.6%], FVC [eight, variance explained (R2 ): 0.5%],
FEV1/FVC [16, variance explained (R2 ): 1.3%] were small
and the statistical power was insufficient. However, the F
statistics (>10, ranging from 32.7 to 21,355.5) for each
SNP and the power of IVs in the mvMR (28, variance
explained (R2 ): 2%; power: 100%) were sufficient, indicating
that those SNPs satisfy the strong relevance assumption
and the weak IV bias would not likely affect the causal

was no evidence for genetic correlations of AF with all lung
function traits (rg = NA, P = NA), namely no coheritability
between two traits. There was evidence for higher genetic
correlations of FEV1 with FVC and FEV1/FVC (FEV1 vs. FVC:
rg = 0.8717, P = 0.0; FEV1 vs. FEV1/FVC: rg = 0.3859,
P = 2.93e-14; FVC vs. FVC: rg = −0.1287, P = 0.0144)
(Table 1).

Genetic IVs Selection and Validation
(Original Analyses)
In the univariable bidirectional MR analyses, we obtained
18/11/10/93 LD-independent SNPs which achieved genome
wide significance (P < 5 × 10−8 ) for FEV1/FVC, FEV1,
FVC, and AF, respectively, then we extracted those SNPs
from corresponding outcome dataset. Finally, 16/9/8/82 SNPs
remained after harmonizing the datasets of exposure and
outcome (2/2/2/11 palindrome SNPs with intermediate allele
frequencies were removed from FEV1/FVC, FEV1, FVC,
and AF).
In mvMR analysis, all 39 (11+10+18) above-mentioned
LD-independent (r2 < 0.0001) SNPs associated with FEV1,
FVC, and FEV1/FVC at P < 5 × 10−8 were included. Five
of these SNPs (rs10888384, rs8033889, rs3754512, rs34712979,
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Genetic IVs Selection and Validation
(Replication Analyses)

inference. The number of IVs included for exposures
were listed in Table 2, and details for the characteristics
of SNPs used in uvMR and mvMR were shown in
Supplementary Tables 1A–C, respectively.

According to the same method as above, we obtained
167/161/186/25 SNPs for FEV1, FVC, FEV1/FVC, and AF,

FIGURE 2 | (A) Leave-one-out plot: MR sensitivity analysis for FEV1 on AF. (B1) Leave-one-out plot: MR sensitivity analysis for FVC on AF (not removing the outlier
SNP). (B2) Leave-one-out plot: MR sensitivity analysis for FVC on AF (removing the outlier SNP). (C) Leave-one-out plot: MR sensitivity analysis for FEV1/FVC on AF.
Each row is interpreted as a Mendelian randomization analysis of the causal effects of FEV1 (A), FVC (B), and FEV1/FVC (C) on AF using the remaining instrumental
variables other than the SNP listed on the y-axis. The dots represent the odds ratio after removing the corresponding SNP, and the lines represent corresponding 95%
confidence interval. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; AF, atrial fibrillation; SNP, single
nucleotide polymorphism.
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TABLE 3 | Forward causal relations of FEV1, FVC, and FEV1/FVC with AF performed by uvMR.
Exposure

nSNPs

OR (95%CI)

P

Q_pval (I2 )

0.719(0)

Intercept (P)

Global P

FEV1 vs. AF
IVW

9

1.031 (0.909–1.169)

0.630

9

1.223 (0.694–2.153)

0.509

WM

9

1.067 (0.905–1.258)

0.442

MR-PRESSO

9

MR-Egger

−0.006 (0.565)

0.776

0.242

FVC vs. AF
IVW

7

1.002 (0.834–1.204)

0.982

MR-Egger

7

0.783 (0.604–5.266)

0.343

WM

7

0.981 (0.807–1.192)

0.844

MR-PRESSO

7

0.158 (0.35)
−0.022 (0.339)

0.421

0.080

FEV1/FVC vs. AF
IVW

16

1.076 (0.966–1.199)

0.182

MR-Egger

16

1.052 (1.178–1.195)

0.006

WM

16

1.099 (0.969–1.246)

0.139

MR-PRESSO

16

0.986

0.064(0.38)
−0.017 (0.012)
0.007

nSNPs, number of single nucleotide polymorphisms; OR, odds ratio; CI, confidence interval; Q_pval, P-value of the Cochran Q statistic; I2 = (Q-df)/Q × 100%; P < 0.017 were considered
statistically significant. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; AF: atrial fibrillation. uvMR, univariable Mendelian
randomization; IVW, inverse-variance weighted; WM, weighted median; MR-PRESSO, Pleiotropy Residual Sum and Outlier.

not alter significantly (IVW: OR = 1.002, 95% CI = 0.834–
1.204, P = 0.982; intercept = −0.022, P = 0.339) (Table 3
and Supplementary Tables 2, 3 and Figure 2B2). No significant
asymmetry was found in the funnel chart, either before or after
the outlier SNP removed (Figures 3B1,B2).

respectively, in the uvMR replication analyses, and 470 SNPs for
lung function in the mvMR analyses. They were described in
detail in the Supplementary Material.

Causal Association of FEV1, FVC, or
FEV1/FVC With AF via Forward MR
(Original Analyses)

FEV1/FVC
All methods except MR Egger regression suggested that
FEV1/FVC has no causal effect on AF (IVW: OR = 1.076,
95% CI = 0.966–1.199, P = 0.182; WM: OR = 1.099, 95% CI
= 0.969–1.246, P = 0.139) without evidence of heterogeneity
(Q_pval = 0.064, I2 = 38%). Although MR Egger estimate was
significant (OR = 1.502, 95% CI = 1.178–1.915, P = 0.006),
overall horizontal pleiotropic effects existed (intercept = −0.017,
P = 0.012), highlighting the need for mvMR analysis. The leaveone-out sensitivity analysis (Figure 2C) and the MR-PRESSO test
both showed that no significant outliers derived the majority
of the association signal (Table 3 and Supplementary Tables 2,
3). The funnel plot indicated no evidence of asymmetry
(Figure 3C).

FEV1
All models suggested that FEV1 has no causal effect on AF (OR
= 1.031, 95% CI = 0.909–1.169, P = 0.630) without evidence of
heterogeneity (Q_pval = 0.719, I2 = 0%) nor pleiotropy effect
(intercept = −0.006, P = 0.565). The WM method estimates
were more precise than the MR-Egger method (WM: OR =
1.067, 95% CI = 0.905–1.258, P = 0.442; MR Egger: OR =
1.223, 95% CI = 0.694–2.153, P = 0.509). The leave-one-out
sensitivity analysis (Figure 2A) indicated that no SNP altered
the MR estimates, suggesting the stability and reliability of the
forward MR results. The MR-PRESSO test detected no SNP as
pleiotropic outlier (Table 3 and Supplementary Tables 2, 3). The
funnel plot indicated no evidence of asymmetry, so there was no
directional pleiotropy (Figure 3A).

Causal Association of AF With FEV1, FVC,
and FEV1/FVC via Reverse MR (Original
Analyses)

FVC
No evidence was detected for a causal relation between FVC
and AF in IVW method (OR = 1.068, 95% CI = 0.874–1.305,
P = 0.519) with no evidence of pleiotropy (intercept = −0.024,
P = 0.361) but moderate heterogeneity (Q_pval = 0.039, I2 =
52%). The leave-one-out sensitivity analysis (Figure 2B1) and
the MR-PRESSO test both detected the third SNP (rs7574127)
as pleiotropic outlier. Although significant heterogeneity was
no longer exist (Q_pval = 0.158, I2 = 35%) after rerun
the MR by removing the outlier SNP, the MR estimates did

Frontiers in Cardiovascular Medicine | www.frontiersin.org

All models in reverse MR analyses consistently suggested that
genetically instrumented AF has no significant correlation
with FEV1 (OR = 0.986, 95% CI = 0.966–1.007, P =
0.187), FVC (OR = 0.985, 95% CI = 0.965–1.006, P =
0.158) and FEV1/FVC (OR = 0.994, 95% CI = 0.973–
1.015, P = 0.545). Pleiotropy bias (interceptFEV1/FVC = 0.002,
PFEV1/FVC = 0.199; interceptFEV1 = 0.001, PFEV1 = 0.747;
interceptFVC = −0.001, PFVC = 0.419) was not detected
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FIGURE 3 | MR funnel plots: FEV1 for AF (A); FVC for AF (B1): not removing the outlier SNP; (B2): removing the outlier SNP; FEV1/FVC for AF (C).

and heterogeneity (FEV1: Q_pval = 0.213, I2 = 11%; FVC:
Q_pval = 0.162, I2 = 13%; FEV1/FVC: Q_pval = 0.127, I2 =
15%) was not found. These main estimates from IVW were
broadly consistent with estimates from the WM and MR-Egger
sensitivity analyses. All reverse leave-one-out sensitivity analyses
(Figures 4A–C) and the MR-PRESSO tests indicated that the
correlation between AF with FEV1, FVC, or FEV1/FVC was
not significantly affected by any individual SNP, indicating
the robustness of the reverse MR analyses results (Table 4
and Supplementary Tables 4, 5). The funnel plot indicated no

Frontiers in Cardiovascular Medicine | www.frontiersin.org

evidence of asymmetry, so there was no directional pleiotropy
(Figures 5A–C).

Causal Association of Lung Function With
AF via mvMR Approach (Original Analyses)
The estimate effects from the mvMR analysis showed that
the direct effect of FEV1 or FVC (ORFEV1 = 0.501, 95%
CI = 0.056–4.457, P = 0.496; ORFVC = 1.969, 95% CI =
0.288–13.474, P = 0.490) controlling for another two lung
function arguments was similar with the univariable setting.
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FIGURE 4 | (A) Leave-one-out plot: MR sensitivity analysis for AF on FEV1. (B) Leave-one-out plot: MR sensitivity analysis for AF on FVC. (C) Leave-one-out plot: MR
sensitivity analysis for AF on FEV1/FVC. Each row is interpreted as a Mendelian randomization analysis of the causal effects of AF on FEV1 (A), FVC (B), and
FEV1/FVC (C) using the remaining instrumental variables other than the SNP listed on the y-axis. The dots represent the odds ratio after removing the corresponding
SNP, and the lines represent the corresponding 95% confidence interval. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the
ratio of FEV1 over FVC; AF, atrial fibrillation; SNP, single nucleotide polymorphism.

DISCUSSION

Additionally, no effect of FEV1/FVC (OR = 1.523, 95%
CI = 0.445–5.217, P = 0.503) on AF could be observed,
which was inconsistent with the univariable MR Egger result.
Consistent with standard IVW regression results, mvMR-Egger
regression (orientated to FEV1/FVC) and MR-PRESSO (detect
no significant outliers) results also showed no significant
association between lung function and AF, suggesting that
the mvMR method successfully overcomes the bias caused by
horizontal pleiotropy in the univariable MR analysis (Table 5 and
Supplementary Table 6).

By performing univariate, multivariate and bidirectional
MR analyses jointly using non-overlapping summary
statistics for lung function and AF, as well as replicating
MR analyses using lung function data including UK
Biobank participants and FinnGen cohort data, we found
that the correlation between impaired lung function and
the risk of AF in published observational studies was
not supported as a causal relationship. These results
were consistent with a series of sensitivity analyses
that were used to explore possible bias caused by
horizontal pleiotropy.
The anatomical and physiological continuity of the lung,
heart and vessels intuitively indicates that damage to any
component of lung function may affect cardiovascular health
(40), and vice versa. The findings of most observational studies
indicate an inverse relation of lung function with AF. However,

Results of the Replication MR Analyses
In the replication MR analyses, there were more IVs and
greater statistical power for lung function but less IVs
for AF, and the MR results were basically consistent with
original results (Table 6). We presented the detailed results
as Supplementary Material.
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TABLE 4 | Reverse causal relations of AF with FEV1, FVC, and FEV1/FVC performed by uvMR.
nSNPs

OR (95%CI)

P

Q_pval (I2 )

IVW

82

0.986 (0.966–1.007)

0.187

0.213 (0.11)

MR-Egger

82

0.979 (0.936–1.026)

0.384

WM

82

0.992 (0.959–1.026)

0.653

MR-PRESSO

82

Exposure

Intercept (P)

Global P

AF vs. FEV1
0.001 (0.747)

0.690

0.076

AF vs. FVC
IVW

82

0.985 (0.965–1.006)

0.158

MR-Egger

82

1.002 (0.957–1.050)

0.922

WM

82

1.001 (0.969–1.034)

0.954

MR-PRESSO

82

0.162 (0.13)
−0.001 (0.419)

0.239

0.084

AF vs. FEV1/FVC
IVW

82

0.994 (0.973–1.015)

0.545

MR-Egger

82

0.967 (0.923–1.013)

0.157

WM

82

0.975 (0.943–1.007)

0.123

MR-PRESSO

82

0.127 (0.15)
0.002 (0.199)

0.484

0.190

nSNPs, number of single-nucleotide polymorphisms; OR, odds ratio; CI, confidence interval; Q_pval, P-value of the Cochran Q statistic; I2 = (Q-df)/Q × 100%; P < 0.017 were considered
statistically significant. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; AF, atrial fibrillation. uvMR, univariable Mendelian
randomization; IVW, inverse-variance weighted; WM, weighted median; MR-PRESSO, Pleiotropy Residual Sum and Outlier.

FIGURE 5 | MR funnel plots: AF for FEV1 (A); AF for FVC (B); AF for FEV1/FVC (C).

TABLE 5 | Multivariable MR analyses for lung function and AF.
Exposure

nSNPs

OR (95% CI)

P

0.496

Intercept P

Q_pval (I2 )

PRESSO P

FEV1
mvIVW

28

0.501 (0.056–4.457)

mvMR-Egger (orientated to FEV1)

28

1.478 (0.201–10.873)

mvIVW

28

1.969 (0.288–13.474)

mvMR-Egger (orientated to FEV1)

28

1.247 (0.335–4.512)

0.502
0.886

FVC
0.490

0.023 (0.634)

0.496

0.361

FEV1/FVC
mvIVW

28

1.523 (0.445–5.217)

mvMR-Egger (orientated to FEV1)

28

0.800 (0.091–7.033)

0.503

0.509
0.299

FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; AF, atrial fibrillation; SE, standard error. mvIVW, multivariable inversevariance weighted; mvMR, multivariable Mendelian randomization; MR-PRESSO, Pleiotropy Residual Sum and Outlier; OR, odds ratio; CI, confidence interval; nSNPs, number of single
nucleotide polymorphisms.
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which could potentially bias estimates of uvMR analyses by
violating the horizontal pleiotropy assumption. Our findings
successfully accounted for the bias by using mvMR analyses.
Although the responsible mechanisms are yet to be defined,
inflammation may be the prominently shared risk factors. The
correlation between declined FEV1 and FEV1/FVC and the
incidence of AF was significantly attenuated after adjusting
the inflammation biomarkers in a cohort study (7); FEV1 and
FVC were inversely correlated with C-reactive protein (CRP)
and fibrinogen in early adulthood (50, 51); the associations
were identified between FEV1 and FVC and circulating levels
of adhesion molecules such as intercellular adhesion molecule
(ICAM) and P-selection (52); indicating that some risks may
be mediated by inflammation. In addition, cardiovascular
diseases (CVDs) and relevant confounding (18, 19) (e.g.,
inefficient clearance of cardiotoxic substance or imbalance of
ventilation/perfusion ratio) may also bring mediating effect in
causal inference between AF and impaired lung function, which
need further investigation.
Two-sample MR analysis is a powerful method for
causal estimate between exposures and outcome using
summary statistic, but we should interpret our findings
with caution because of the following limitations. First,
although both lung function and AF studies were based
on European population with no cohort overlap between
the meta-analysis, but might have some sample overlap,
which would lead to inflation of Type 1 error rate (53).
In addition, the two GWAS we used were both adjusted
for age, height, gender and smoking, which may produce
collider bias and lead to identification of invalid IVs and
thus affect the interpretability and validity of the results
(54). Lastly, the results exhibited a lack of evidence from
non-European populations.
In conclusion, a causal relationship of impaired lung function
with AF was not evident in this study. Even so, it does not
hint that improvement of lung function in AF patients and
preventing the AF risk in patients with impaired lung function
are unnecessary. In addition, lung function and AF were both
associated with inflammation, which may be potential pathway,
warranting further study. New generations of GWAS with a
higher explanatory efficacy and more representative population
should be explored and investigated in further researches.

TABLE 6 | Main results of the replication MR analyses.
Exposure

nSNPs

OR (95%CI)

P

Q_pval (I2 )

FEV1 vs. AF

159

0.844 (0.735–0.969)

0.016

0.035 (0.18)

FVC vs. AF

155

0.906 (0.781–1.052)

0.197

0.029 (0.18)

FEV1/FVC vs. AF

185

1.021 (0.930–1.122)

0.657

0.469 (0.00)

AF vs. FEV1

24

0.991 (0.980–1.002)

0.124

0.014 (0.43)

AF vs. FVC

19

0.947 (0.878–1.022)

0.161

0.602 (0.00)

AF vs. FEV1/FVC

12

0.997 (0.896–1.110)

0.956

0.282 (0.17)

470

0.375 (0.038–3.693)

0.400

0.473 (0.002)

FEV1
FVC vs. AF
FEV1/FVC
nSNPs, number of single nucleotide polymorphisms; OR, odds ratio; CI, confidence
interval; Q_pval, P-value of the Cochran Q statistic; I2 = (Q-df)/Q×100%; P < 0.017 were
considered statistically significant. FEV1, forced expiratory volume in one second; FVC,
forced vital capacity; FEV1/FVC, the ratio of FEV1 over FVC; AF, atrial fibrillation.

these analyses were derived from a set of heterogeneous
studies, with varying levels of adjustments for confounders
such as age, height and smoking, which are in themselves
also known risk factors for the development of AF and
impaired lung function. The attributable fraction of the
population with known risk factors has been estimated to be
about one-half, indicating that there may be additional risk
factors which are not fully elaborated (41–43). Obviously, the
regression models could not fully represent the biological
complexity of common risk factors affecting lung and
heart health.
Consistent with the causal inference on lung function and
AF from the newest two sample bidirectional MR study (25),
which used UK Biobank summary statistics of FEV1 and FVC
and the same AF dataset (including UK Biobank individuals)
as ours, we found no evidence of a causal association between
FEV1, FVC, and AF. Moreover, consistent results were obtained
in the recurring MR analyses. Another MR study (44) found
that taller people had higher risk of AF and considering part
instruments of the lung function were also related to height,
which may account for the invalid results of height adjustment
in GWAS summary data. Furthermore, the positive relation of
FEV1/FVC with AF in our uvMR Egger analysis is somewhat
unexpected although the association disappeared after adjusting
for FEV1 and FVC in mvMR method. Observational study
(45) indicated that impaired FEV1 and FVC was related to
larger left ventricular mass; impaired FEV1/FVC was related
to smaller left atrial internal dimension, as well as FEV1
is a measure of severity of airway obstruction while FVC
represents overall vital capacity (46). It can be seen that
differential pattern of lung function decline reflect distinct
effects on cardiopulmonary phenotypes. In terms of genetic
mechanisms, the multiple gene regions associated with FEV1 play
roles in biological pathways of inflammation, morphogenesis
and development; FVC play roles in lung tissue repair, and
FEV1/FVC play roles in inflammation and morphogenesis
or development (47–49). Thus, we can see that different
arguments of lung function may share genetic mechanisms,
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